Nutritional and metabolic study in coronary disease
Arteaga, A.; Soto, S.; Valdivieso, J.; Casanegra, P.; Millon, P.; Campano, M.; Ortiz, C.L.; Ortiz, L.M.; Acosta, A.M.
Revista Medica de Chile 101(7): 519-523
1973
ISSN/ISBN: 0034-9887 PMID: 4769457 Document Number: 66201
Document emailed within 1 workday
Related Documents
Mori, T.; Ohashi, Y.; Ejiri, J.; Takatsuki, K.; Ichikawa, S.; Awano, K. 2005: Impact of metabolic syndrome and diabetes mellitus on cardiovascular events in coronary artery disease without ischemia on stress thallium-201 single photon emission computed tomography after percutaneous coronary intervention Journal of Cardiology 46(3): 89-96Bialkowska, M.; Cybulska, B.; Szostak, W.B. 1972: Some metabolic indices in coronary arterial disease Polski Tygodnik Lekarski 27(40): 1550-1553
Arntz, H.R.; Wunderlich, W.; Schnitzer, L.; Stern, R.; Fischer, F.; Agrawal, R.; Linderer, T.; Schultheiss, H.P. 1999: Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study Zeitschrift für Kardiologie 88(8): 582-590
Haffner, S.M. 2002: Metabolic syndrome, diabetes and coronary heart disease International Journal of Clinical Practice. Suppl 132: 31-37
Meller, S.M.; Stilp, E.; Walker, C.N.; Mena-Hurtado, C. 2013: The link between vasculogenic erectile dysfunction, coronary artery disease, and peripheral artery disease: role of metabolic factors and endovascular therapy Journal of Invasive Cardiology 25(6): 313-319
Kratnov, A.E.; Khabarova, I.V. 2009: Neutrophilic intracellular metabolic changes and fatal outcome in coronary heart disease Klinicheskaia Laboratornaia Diagnostika 1: 20-22
Cortez-Dias, N.; Martins, S.; Belo, A.; Fiuza, M. 2011: Comparison of definitions of metabolic syndrome in relation to risk for coronary artery disease and stroke Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 30(2): 139-169
Gong, X.; Pan, X.; Chen, X.; Hong, C.; Hong, J.; Shen, F. 2012: Associations between coronary heart disease and individual components of the metabolic syndrome according to glucose tolerance status Journal of International Medical Research 40(3): 934-942
Popescu, P.; Anghel, S.; Idu, S.; Mihai, N.; Moldovan, T.; Mihail, A. 1974: On the intravenous tolbutamide test (ivTT) in patients with coronary disease. (Glucide-lipid metabolic relationships) Medicina Interna 26(4): 445-452
Kravchun, P.G.; Kadykova, O.I.; Molotyagin, D.G. 2019: Changes in pentraxin-3 level and its interaction with metabolic indices in patients with coronary artery disease and type 2 diabetes mellitus Wiadomosci Lekarskie 72(2): 181-185
Szybínski, Z.; Sznajd, J.; Sieradzki, J.; Magdoń, M.; Mruk, K.; Olszanecki, S. 1976: Structure and basic activities of a consultation unit on metabolic disorders within the programme for prevention of coronary heart disease Przeglad Lekarski 33(6): 579-582
Kou, W.R.; Gao, R.L.; Chen, Z.J. 1987: A correlative study of thallium-201 myocardial imaging, electrocardiography and coronary arteriography in 50 patients with coronary heart disease Zhonghua Xin Xue Guan Bing Za Zhi 15(2): 89-91 127
Li, X.; Song, J.P.; Wang, K.P. 1992: A comparative study of coronary arteriography and myocardial emission computed tomography in the diagnosis of coronary heart disease Zhonghua Nei Ke Za Zhi 31(10): 611
Erkkilä, A.T.; Lindi, V.; Lehto, S.; Pyörälä, K.; Laakso, M.; Uusitupa, M.I.J. 2002: Variation in the fatty acid binding protein 2 gene is not associated with markers of metabolic syndrome in patients with coronary heart disease Nutrition Metabolism and Cardiovascular Diseases: Nmcd 12(2): 53-59
Khanna, R.; Kapoor, A.; Kumar, S.; Tewari, S.; Garg, N.; Goel, P.K. 2013: Metabolic syndrome and Framingham Risk Score: observations from a coronary angiographic study in Indian patients Indian Journal of Medical Research 137(2): 295-301
Nahser, P.J.; Brown, R.E.; Oskarsson, H.; Winniford, M.D.; Rossen, J.D. 1995: Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus Circulation 91(3): 635-640
Rickenbacher, P.R.; Kemna, M.S.; Pinto, F.J.; Hunt, S.A.; Alderman, E.L.; Schroeder, J.S.; Stinson, E.B.; Popp, R.L.; Chen, I.; Reaven, G.; Valantine, H.A. 1996: Coronary artery intimal thickening in the transplanted heart. An in vivo intracoronary untrasound study of immunologic and metabolic risk factors Transplantation 61(1): 46-53
Kalyuzhin, V.V.; Teplyakov, A.T.; Pushnikova, E.Y.; Bespalova, L.D.; Kalyuzhina, E.V.; Kolesnikov, R.N. 2013: Comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome Terapevticheskii Arkhiv 85(5): 68-72
Fukai, M.; Ii, M.; Nakakoji, T.; Kawakatsu, M.; Nariyama, J.; Yokota, N.; Negoro, N.; Kojima, S.; Ohkubo, T.; Hoshiga, M.; Nakajima, O.; Ishihara, T. 2000: Angiographically demonstrated coronary collaterals predict residual viable myocardium in patients with chronic myocardial infarction: a regional metabolic study Journal of Cardiology 35(2): 103-111
Sartipy, U.; Lindblom, D. 2009: New study on surgery in coronary disease and heart failure. of what value is left ventricular reconstruction in addition to coronary surgery? Lakartidningen 106(40): 2522; 2524